Experts have said for years that measles would make a comeback if vaccination rates continued to fall, and 2025 lent credence ...

The CDC has officially updated its immunization schedule to reflect its Advisory Committee on Immunization Practices’ ...

A former NIH official who was fired after filing a whistleblower complaint that alleged she was removed from her position for ...

In this video, Brian T. Hill, MD, PhD, discusses data from the phase 3 EPCORE FL-1 trial, presented at the ASH Annual Meeting and Exposition.The research compared a triple drug combination therapy of ...

Cataract surgery has undergone remarkable refinement over the past decades, yet some of the most elegant maneuvers remain ...

In this video, Matthew S. Davids, MD, spoke about the BRUIN-314 trial, one of the first head-to-head studies to compare pirtobrutinib, a noncovalent Bruton tyrosine kinase inhibitor, with ibrutinib, a ...

Pregnancy, menopause and hormone therapy may all impact a woman’s lipoprotein(a) level, challenging the mantra of the once-in ...

In this video, Carolyn K. Pan, MD, a clinical professor of ophthalmology at Stanford University, discussed highlights in wet ...

Results presented at IDWeek showed prolonged antibiotic therapy beyond 12 weeks may not improve outcomes for early ...

As physicians across specialties encounter increasing patient interest in GLP-1 receptor agonists, it is important for them ...

Combining elacestrant with targeted agents produced “clinically meaningful” outcomes for patients with locally advanced or metastatic ER-positive/HER2-negative breast cancer who have received at least ...

Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...